[HTML][HTML] Recent advances in mass spectrometry based clinical proteomics: applications to cancer research
A Macklin, S Khan, T Kislinger - Clinical proteomics, 2020 - Springer
Cancer biomarkers have transformed current practices in the oncology clinic. Continued
discovery and validation are crucial for improving early diagnosis, risk stratification, and …
discovery and validation are crucial for improving early diagnosis, risk stratification, and …
Clinical applications of mass spectrometry‐based proteomics in cancer: Where are we?
EL Boys, J Liu, PJ Robinson, RR Reddel - Proteomics, 2023 - Wiley Online Library
Tumor tissue processing methodologies in combination with data‐independent acquisition
mass spectrometry (DIA‐MS) have emerged that can comprehensively analyze the …
mass spectrometry (DIA‐MS) have emerged that can comprehensively analyze the …
The evolving role of mass spectrometry in cancer biomarker discovery
Although the field of mass spectrometry-based proteomics is still in its infancy, recent
developments in targeted proteomic techniques have left the field poised to impact the …
developments in targeted proteomic techniques have left the field poised to impact the …
Proteomics-driven cancer biomarker discovery: looking to the future
RJ Simpson, OK Bernhard, DW Greening… - Current opinion in …, 2008 - Elsevier
Availability of a suite of biomarkers for early detection, stratification into distinct subtypes,
and monitoring progression or response to therapy promises significant improvements in …
and monitoring progression or response to therapy promises significant improvements in …
[HTML][HTML] Mass spectrometry-based proteomics as an emerging tool in clinical laboratories
AG Birhanu - Clinical Proteomics, 2023 - Springer
Mass spectrometry (MS)-based proteomics have been increasingly implemented in various
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …
disciplines of laboratory medicine to identify and quantify biomolecules in a variety of …
Clinical potential of mass spectrometry-based proteogenomics
Cancer genomics research aims to advance personalized oncology by finding and targeting
specific genetic alterations associated with cancers. In genome-driven oncology, treatments …
specific genetic alterations associated with cancers. In genome-driven oncology, treatments …
Cancer proteomics
HT Tan, YH Lee, MCM Chung - Mass spectrometry reviews, 2012 - Wiley Online Library
Cancer presents high mortality and morbidity globally, largely due to its complex and
heterogenous nature, and lack of biomarkers for early diagnosis. A proteomics study of …
heterogenous nature, and lack of biomarkers for early diagnosis. A proteomics study of …
[HTML][HTML] Mass spectrometry for translational proteomics: progress and clinical implications
The utility of mass spectrometry (MS)-based proteomic analyses and their clinical
applications have been increasingly recognized over the past decade due to their high …
applications have been increasingly recognized over the past decade due to their high …
Mass spectrometry in clinical proteomics–from the present to the future
MS is an important analytical tool in clinical proteomics, primarily in the disease‐specific
discovery, identification and characterisation of proteomic biomarkers and patterns. MS …
discovery, identification and characterisation of proteomic biomarkers and patterns. MS …
[HTML][HTML] Mass spectrometry-assisted gel-based proteomics in cancer biomarker discovery: approaches and application
R Huang, Z Chen, L He, N He, Z Xi, Z Li, Y Deng… - Theranostics, 2017 - ncbi.nlm.nih.gov
There is a critical need for the discovery of novel biomarkers for early detection and targeted
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …
therapy of cancer, a major cause of deaths worldwide. In this respect, proteomic …